Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/18189
Title: Efficacy of oral vancomycin in recurrent primary sclerosing cholangitis following liver transplantation.
Authors: Hey, Penelope;Lokan, Julie;Johnson, Paul D R;Gow, Paul
Affiliation: Department of Gastroenterology, Austin Health, Heidelberg, Victoria, Australia
Department of Pathology, Austin Health, Heidelberg, Victoria, Australia
Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia
Issue Date: 25-Sep-2017
EDate: 2017
Citation: BMJ case reports 2017; online first: 25 September
Abstract: Primary sclerosing cholangitis (PSC) is a liver disease that leads to progressive destruction and stricturing of the biliary tree. Unfortunately, apart from orthotopic liver transplantation (OLT), there are no universally accepted therapies to treat this disease. Even following transplantation, recurrence of PSC is seen in approximately one quarter of patients and leads to high rates of graft failure. Oral vancomycin, through possible immunomodulatory and anti-inflammatory mechanisms, has been shown in small-scale studies to be successful in improving liver function tests in patients with pretransplant PSC. We report the first case of an adult patient diagnosed with recurrent PSC 4 years after OLT who was treated with oral vancomycin leading to complete normalisation of his liver biochemistry. This case adds to the growing literature of a potential therapeutic role for this antibiotic in PSC and highlights interesting questions regarding mechanisms of disease.
URI: http://ahro.austin.org.au/austinjspui/handle/1/18189
DOI: 10.1136/bcr-2017-221165
PubMed URL: 28951512
Type: Case Reports
Journal Article
Subjects: biliary intervention
cirrhosis
portal hypertension
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.